Tissue damage in the amyloidoses: Transthyretin monomers and nonnative oligomers are the major cytotoxic species in tissue culture
Top Cited Papers
- 23 February 2004
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 101 (9) , 2817-2822
- https://doi.org/10.1073/pnas.0400062101
Abstract
The transthyretin (TTR) amyloidoses are human diseases in which the misfolded TTR protein aggregates in tissues with subsequent visceral, peripheral, and autonomic nerve dysfunction. Recent reports have stressed the importance of oligomeric intermediates as major cytotoxic species in various forms of amyloidogenesis. We have examined the cytotoxic effects of several quaternary structural states of wild-type and variant TTR proteins on cells of neural lineage. TTR amyloid fibrils and soluble aggregates >100 kDa were not toxic. Incubation of TTR under the conditions of the cell assay and analysis by size-exclusion chromatography and SDS/PAGE reveal that monomeric TTR or relatively small, rapidly formed aggregates of a maximum size of six subunits were the major cytotoxic species. Small molecules that stabilize the native tetrameric state were shown to prevent toxicity. The studies are consistent with a model in which the misfolded TTR monomer rapidly aggregates to form transient low molecular mass assemblies (<100 kDa) that are highly cytotoxic in tissue culture.Keywords
This publication has 23 references indexed in Scilit:
- Diseases of protein conformation: what do in vitro experiments tell us about in vivo diseases?Trends in Biochemical Sciences, 2003
- Molecular Mechanisms of AmyloidosisNew England Journal of Medicine, 2003
- D18G Transthyretin Is Monomeric, Aggregation Prone, and Not Detectable in Plasma and Cerebrospinal Fluid: A Prescription for Central Nervous System Amyloidosis?Biochemistry, 2003
- Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of PathogenesisScience, 2003
- Prevention of Transthyretin Amyloid Disease by Changing Protein Misfolding EnergeticsScience, 2003
- Spontaneous Aggregation and Cytotoxicity of the β-Amyloid Aβ1–40: A Kinetic ModelProtein Journal, 2003
- Only amyloidogenic intermediates of transthyretin induce apoptosisBiochemical and Biophysical Research Communications, 2002
- Therapeutic strategies for human amyloid diseasesNature Reviews Drug Discovery, 2002
- Rational design of potent human transthyretin amyloid disease inhibitors.Nature Structural & Molecular Biology, 2000
- The Genetics of the AmyloidosesAnnual Review of Medicine, 2000